Search Orphan Drug Designations and Approvals
-
Generic Name: | ombitasvir/paritaprevir/ritonavir and dasabuvir |
---|---|
Date Designated: | 07/16/2015 |
Orphan Designation: | Treatment of pediatric patients with hepatitis C virus infection (0 through 16 years of age) |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Abbvie, Inc. 1 North Waukegan Road North Chicago, Illinois 60064 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-